Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Mod Rheumatol ; 25(3): 472-5, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-24252017

RESUMEN

Cardiac involvement can affect up to 50% of the systemic lupus erythematosus (SLE) patients but conduction system disturbances in SLE are less commonly described. For an early detection of this complication in the acute phase of SLE a whole cardiovascular examination and periodic electrocardiographic monitoring are recommended. We describe a patient who was diagnosed with flare up of lupus activity manifesting as sinus node dysfunction presenting as profound sinus bradycardia. She was successfully treated with high-dose methylprednisolone therapy.


Asunto(s)
Bradicardia/etiología , Lupus Eritematoso Sistémico/complicaciones , Síndrome del Seno Enfermo/etiología , Bradicardia/tratamiento farmacológico , Bradicardia/fisiopatología , Femenino , Glucocorticoides/uso terapéutico , Humanos , Lupus Eritematoso Sistémico/tratamiento farmacológico , Lupus Eritematoso Sistémico/fisiopatología , Metilprednisolona/uso terapéutico , Síndrome del Seno Enfermo/tratamiento farmacológico , Síndrome del Seno Enfermo/fisiopatología , Resultado del Tratamiento , Adulto Joven
2.
Intern Med ; 53(7): 703-5, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24694480

RESUMEN

Gastrointestinal toxicity is uncommon among patients treated with angiotensin II receptor antagonists. A 58-year-old man presented with nausea, vomiting and constant pain in the epigastrium that radiated to the flanks. He received treatment with valsartan (160 mg daily) for hypertension. The clinical, biochemical and radiological findings were compatible with a diagnosis of acute pancreatitis. After the patient achieved a clinical and biochemical recovery, the valsartan therapy was started again. Six weeks later, he returned to the hospital with an attack of pancreatitis. Subsequently, he returned with repeated attacks of pancreatitis twice, and the valsartan was discontinued. Ten months after the treatment, the patient had no complaints. When severe abdominal symptoms occur for no apparent reason during treatment with valsartan, a diagnosis of pancreatitis should be considered.


Asunto(s)
Hipertensión/tratamiento farmacológico , Pancreatitis Aguda Necrotizante/inducido químicamente , Tetrazoles/efectos adversos , Valina/análogos & derivados , Bloqueadores del Receptor Tipo 1 de Angiotensina II/efectos adversos , Bloqueadores del Receptor Tipo 1 de Angiotensina II/uso terapéutico , Colangiopancreatografia Retrógrada Endoscópica , Pancreatocolangiografía por Resonancia Magnética , Diagnóstico Diferencial , Humanos , Masculino , Persona de Mediana Edad , Pancreatitis Aguda Necrotizante/diagnóstico , Pancreatitis Aguda Necrotizante/cirugía , Esfinterotomía Endoscópica/métodos , Tetrazoles/uso terapéutico , Valina/efectos adversos , Valina/uso terapéutico , Valsartán
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA